Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base

Autor: Zhifei Sun, Paul J. Speicher, Matthew G. Hartwig, David H. Harpole, Shakir M. Saud, Thomas A. D'Amico, Brian C. Gulack, Betty C. Tong, Mark W. Onaitis, Mark F. Berry, Chi-Fu Jeffrey Yang
Rok vydání: 2016
Předmět:
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
Population
030204 cardiovascular system & hematology
Article
03 medical and health sciences
Pneumonectomy
Postoperative Complications
0302 clinical medicine
Carcinoma
Non-Small-Cell Lung

Carcinoma
medicine
Humans
Registries
Propensity Score
education
Survival rate
Aged
Neoplasm Staging
Retrospective Studies
education.field_of_study
Thoracic Surgery
Video-Assisted

business.industry
Incidence
Puerto Rico
Retrospective cohort study
Robotics
Perioperative
medicine.disease
United States
Surgery
Survival Rate
Treatment Outcome
Cardiothoracic surgery
030220 oncology & carcinogenesis
Propensity score matching
Female
Cardiology and Cardiovascular Medicine
business
human activities
Follow-Up Studies
Zdroj: The Annals of Thoracic Surgery. 101:1037-1042
ISSN: 0003-4975
Popis: Previous studies have raised concerns that video-assisted thoracoscopic (VATS) lobectomy may compromise nodal evaluation. The advantages or limitations of robotic lobectomy have not been thoroughly evaluated.Perioperative outcomes and survival of patients who underwent open versus minimally-invasive surgery (MIS [VATS and robotic]) lobectomy and VATS versus robotic lobectomy for clinical T1-2, N0 non-small cell lung cancer from 2010 to 2012 in the National Cancer Data Base were evaluated using propensity score matching.Of 30,040 lobectomies, 7,824 were VATS and 2,025 were robotic. After propensity score matching, when compared with the open approach (n = 9,390), MIS (n = 9,390) was found to have increased 30-day readmission rates (5% versus 4%, p0.01), shorter median hospital length of stay (5 versus 6 days, p0.01), and improved 2-year survival (87% versus 86%, p = 0.04). There were no significant differences in nodal upstaging and 30-day mortality between the two groups. After propensity score matching, when compared with the robotic group (n = 1,938), VATS (n = 1,938) was not significantly different from robotics with regard to nodal upstaging, 30-day mortality, and 2-year survival.In this population-based analysis, MIS (VATS and robotic) lobectomy was used in the minority of patients for stage I non-small cell lung cancer. MIS lobectomy was associated with shorter length of hospital stay and was not associated with increased perioperative mortality, compromised nodal evaluation, or reduced short-term survival when compared with the open approach. These results suggest the need for broader implementation of MIS techniques.
Databáze: OpenAIRE